93 related articles for article (PubMed ID: 20883161)
1. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines.
Wu S; Kanda T; Imazeki F; Arai M; Yonemitsu Y; Nakamoto S; Fujiwara K; Fukai K; Nomura F; Yokosuka O
Viral Immunol; 2010 Oct; 23(5):467-76. PubMed ID: 20883161
[TBL] [Abstract][Full Text] [Related]
2. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
Wu JF; Hsu HY; Ni YH; Chen HL; Wu TC; Chang MH
Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
[TBL] [Abstract][Full Text] [Related]
4. Early inhibition of hepatocyte innate responses by hepatitis B virus.
Luangsay S; Gruffaz M; Isorce N; Testoni B; Michelet M; Faure-Dupuy S; Maadadi S; Ait-Goughoulte M; Parent R; Rivoire M; Javanbakht H; Lucifora J; Durantel D; Zoulim F
J Hepatol; 2015 Dec; 63(6):1314-22. PubMed ID: 26216533
[TBL] [Abstract][Full Text] [Related]
5. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
Yang HC; Chen CL; Shen YC; Peng CY; Liu CJ; Tseng TC; Su TH; Chuang WL; Yu ML; Dai CY; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
[TBL] [Abstract][Full Text] [Related]
6. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes.
Wilson R; Warner N; Ryan K; Selleck L; Colledge D; Rodgers S; Li K; Revill P; Locarnini S
J Viral Hepat; 2011 Oct; 18(10):e499-507. PubMed ID: 21914069
[TBL] [Abstract][Full Text] [Related]
8. Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody.
Walsh R; Nuttall S; Revill P; Colledge D; Cabuang L; Soppe S; Dolezal O; Griffiths K; Bartholomeusz A; Locarnini S
Virology; 2011 Mar; 411(1):132-41. PubMed ID: 21239030
[TBL] [Abstract][Full Text] [Related]
9. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.
Hultgren C; Milich DR; Weiland O; Sällberg M
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2381-91. PubMed ID: 9780043
[TBL] [Abstract][Full Text] [Related]
10. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
[TBL] [Abstract][Full Text] [Related]
11. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
Kim HJ; Yoo BC
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
[TBL] [Abstract][Full Text] [Related]
12. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen.
Kang EH; Kown TY; Oh GT; Park WF; Park SI; Park SK; Lee YI
Antiviral Res; 2006 Nov; 72(2):100-6. PubMed ID: 16720052
[TBL] [Abstract][Full Text] [Related]
13. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
Visvanathan K; Skinner NA; Thompson AJ; Riordan SM; Sozzi V; Edwards R; Rodgers S; Kurtovic J; Chang J; Lewin S; Desmond P; Locarnini S
Hepatology; 2007 Jan; 45(1):102-10. PubMed ID: 17187404
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
16. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
19. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence.
Milich DR; Chen MK; Hughes JL; Jones JE
J Immunol; 1998 Feb; 160(4):2013-21. PubMed ID: 9469465
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
